| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis & Rheumatism 65 (11), 2737-2747, 2013 | 5352 | 2013 |
| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, A Tyndall, ... Wiley Periodicals, Inc., 2013 | 718 | 2013 |
| Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial D Khanna, CP Denton, A Jahreis, JM van Laar, TM Frech, ME Anderson, ... The lancet 387 (10038), 2630-2640, 2016 | 684 | 2016 |
| A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma JE Pope, N Bellamy, JR Seibold, M Baron, M Ellman, S Carette, CD Smith, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 535 | 2001 |
| Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia S Carette, MJ Bell, WJ Reynolds, B Haraoui, GA Mccain, VP Bykerk, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1994 | 523 | 1994 |
| Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis D Khanna, DE Furst, PJ Clements, Y Allanore, M Baron, L Czirjak, ... Journal of scleroderma and related disorders 2 (1), 11-18, 2017 | 497 | 2017 |
| Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis Y Wu, B Levis, KE Riehm, N Saadat, AW Levis, M Azar, DB Rice, J Boruff, ... Psychological medicine 50 (8), 1368-1380, 2020 | 296 | 2020 |
| Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey M Bassel, M Hudson, SS Taillefer, O Schieir, M Baron, BD Thombs Rheumatology 50 (4), 762-767, 2011 | 296 | 2011 |
| Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate) D Khanna, CP Denton, CJF Lin, JM Van Laar, TM Frech, ME Anderson, ... Annals of the rheumatic diseases 77 (2), 212-220, 2018 | 283 | 2018 |
| Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis MD Mayes, L Bossini-Castillo, O Gorlova, JE Martin, X Zhou, WV Chen, ... The American Journal of Human Genetics 94 (1), 47-61, 2014 | 256 | 2014 |
| Health‐related quality of life in systemic sclerosis: a systematic review M Hudson, BD Thombs, R Steele, P Panopalis, E Newton, M Baron, ... Arthritis Care & Research 61 (8), 1112-1120, 2009 | 235 | 2009 |
| Mortality in systemic sclerosis (scleroderma) P Lee, P Langevitz, CA Alderdice, M Aubrey, PA Baer, M Baron, D Buskila, ... QJM: An International Journal of Medicine 82 (2), 139-148, 1992 | 233 | 1992 |
| Depression in patients with systemic sclerosis: a systematic review of the evidence BD Thombs, SS Taillefer, M Hudson, M Baron Arthritis Care & Research 57 (6), 1089-1097, 2007 | 222 | 2007 |
| Early mortality in a multinational systemic sclerosis inception cohort Y Hao, M Hudson, M Baron, P Carreira, W Stevens, C Rabusa, ... Arthritis & rheumatology 69 (5), 1067-1077, 2017 | 210 | 2017 |
| The articular manifestations of progressive systemic sclerosis (scleroderma). M Baron, P Lee, EC Keystone Annals of the rheumatic diseases 41 (2), 147-152, 1982 | 204 | 1982 |
| Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis D Lagares, A Santos, PE Grasberger, F Liu, CK Probst, RA Rahimi, ... Science translational medicine 9 (420), eaal3765, 2017 | 202 | 2017 |
| Health services costs and their determinants in women with fibromyalgia. JR Penrod, S Bernatsky, V Adam, M Baron, N Dayan, PL Dobkin The Journal of rheumatology 31 (7), 1391-1398, 2004 | 197 | 2004 |
| The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a … G Valentini, M Iudici, UA Walker, VK Jaeger, M Baron, P Carreira, ... Annals of the rheumatic diseases 76 (1), 270-276, 2017 | 191 | 2017 |
| Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates K Milette, M Hudson, M Baron, BD Thombs, ... Rheumatology 49 (4), 789-796, 2010 | 189 | 2010 |
| Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative F van den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis and rheumatism 65 (11), 2737, 2013 | 183 | 2013 |
